ARCHIVES

FDA Issues Final Rules On Patient Access To Investigational Drugs

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

March 3, 2006

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Gavel Changes Hands At NCAB, Korn advises New Members On Role

February 8, 1991